Multi-disciplinary care is vital for the treatment of complex patients, especially those with rare diseases. The benefits of multi-disciplinary collaboration go beyond clinical outcomes and include research.
Unconscious bias can play a role in both clinical care and patient experiences. Determining the presence and magnitude of inequity can be methodologically challenging in children’s research. This presentation will frame opportunities to investigate and address inequities through the lens of improvement science using patient safety as a model.
We are all problem solvers. We are accustomed to applying the scientific method and quality improvement models to deliver better care. Design thinking is an approach to solving problems that emphasizes a human-centred and iterative process to create innovative solutions. Six years ago, we invited design students into the PICU to see if we could find better ways of teaching congenital heart disease. This is the story of that journey.
Scientific advances now allow researchers to identify, isolate and engineer stem cells. reNEW aims to deliver treatment outcomes across the breadth of stem cell medicine – new drugs based on human stem cell models, new tissue therapies, and new cell and gene therapies. We look forward to presenting how stem cell medicine and reNEW are advancing treatments for delivery into the clinic across many currently untreatable diseases.
In three parts, this Grand Round intends to describe the significant developments in the management of musculoskeletal conditions associated with cerebral palsy. First, the critical role that the Victorian Cerebral Palsy Register (VCPR) has played in epidemiological research, clinical research, and public health policy will be outlined. The second section will discuss technical developments in the management of Neuromuscular Hip Dysplasia, including novel imaging techniques and new aids for surgeons when considering surgical treatment. The final section will focus on common gait problems in children with cerebral palsy, as well as novel treatment concepts
This year’s NAIDOC Week Theme, ‘For Our Elders’ celebrates the valuable contribution of Aboriginal and Torres Strait Islander Elders in all areas of Australia. Please join Melbourne Children’s Campus leaders in Aboriginal and Torres Islander healthcare in a panel discussion about the crucial role that Elders play in our services, programs, care and research. The panel aims to acknowledge and celebrate the often hidden guidance, influence and advocacy of Elders in health.
Meta-analyses show that medication is an effective treatment pathway in children and adolescents diagnosed with ADHD. These medications are also commonly associated with a number of side effects and risk factors for other conditions, which are less well understood by practitioners. This Grand Round intends to balance understanding of the efficacy of ADHD medication with the potential risks, and provide evidence for the safety of ADHD medication prescription in clinical practice.
The Centre for Health Analytics launched to the Campus in June 2021. With two years of enabling the Campus to better use our data, the Centre will share successes and lessons learned across their journey.
In recent years there has been increasing policy attention paid to child mental health, at a state and national level, given the marked increase in mental health problems in children. In addition to causing distress for children and families, when mental health difficulties are not addressed in a timely way, they can become entrenched and have serious effects into adult life.
The Bacille Calmette-Guérin (BCG) vaccine, a 100-year-old vaccine usually given to protect against tuberculosis, also has ‘off-target’ effects on the immune system that protect against other infections and allergic diseases.
